key: cord-1029054-26bl1jy4 authors: Pyra, Maria; Rusie, Laura; Houlberg, Magda; Balthazar, Christopher; Montgomery, Jerome; Hotton, Anna; Yang, Wenho; Betanzos, Mateo; Green, Maya; Schneider, John title: COVID-19 Testing Results by HIV Status, March-July 2020, Chicago, USA date: 2021-02-02 journal: Open Forum Infect Dis DOI: 10.1093/ofid/ofab053 sha: 59438bb2de5d280c8fc8e8ab97f9acf69c580a34 doc_id: 1029054 cord_uid: 26bl1jy4 The role of HIV in COVID-19 acquisition is not yet understood. Among 1862 patients, including 349 PLWHIV, most virally suppressed, and 308 recently using PrEP, we compared rates of positive PCR results. Positivity was higher among PLWHIV (10.6%) compared to HIV negative patients (7.1%) but not significant in adjusted models. As SARS-CoV-2 is still a novel pathogen, many questions remain unanswered. While some comorbidities and risk factors have been identified, little is known regarding how HIV status affects COVID-19 acquisition. Outcomes among cohorts of people living with HIV (PLWHIV) in New York, Italy, Spain, China, and South Africa have been been reported 1-6 , generally but not always finding no increase in adverse outcomes among PLWHIV. Recent work in the U.S. has found that social & environmental risks as well as other comorbidities were frequent among COVID-19-positive PLWHIV 7 . This project aims to understand whether HIV increases the risk of being PCR-positive for COVID-19, using a retrospective cohort. Starting March 13, 2020, Howard Brown Health (HBH), as federally qualified health center focusing on sexual and gender minority care, began using clinic sites, mobile health units, and community testing sites to expand access and increase COVID-19 testing in the highest risk communities in Chicago, regardless of sexual orientation or gender. Community partnerships with Project VIDA and Taskforce were strategically used to improve testing in populations outside the existing patient pool. Testing visits involved nasopharyngeal tests were performed by providers and were sent to a local lab; results were available within 3-10 days. Data was abstracted from the electronic medical record of all testing sites from March 13 to July 22, 2020. All patients in this analysis had at least one HBH visit prior to their first COVID PCR test. Descriptive statistics are presented on all clients screened using RT-PCR during this period, with additional data from patient's prior EMR records. Any tests after a patient's first positive test result are excluded, as were indeterminate and pending results. We present 95% CI for positivity rates for readers to assess the precision of the estimates; however, criteria for testing changed over time and the rates are not adjusted for temporal trends. We then used GEE models (to account for repeated observations) with a logit link to model the odds of having a positive test result; patients age 10-19 were excluded from the models, due to small sample size. Weeks 22 & 25 were also excluded, as there were no or few tests that week due to protests in the city (see Figure 1 ). The model was first adjusted only for testing week and then for all variables (age, race, gender, orientation, insurance, and HIV status) including testing week. All analyses were conducted in SAS 4.0 and the University of Chicago IRB approved this study and waived consent. Overall, 1862 HBH patients received 2010 tests results during the analysis period. Patients were primary 20-39 years old (65%) and White (45%), with 25% identifying as Black and 22% as Latinx. Most identified as cismen (62%) and half as gay. The sample was mostly representative of the general HBH patient population (defined as those with a visit between October 2019 and February 2020); however, among patients a higher proportion of English-speaking, genderqueer, gay, privately insured, Chicago-based, and PLWHIV were tested, while those identified as straight and from other parts of IL were less likely to be tested. There were 349 PLWHIV, 292 of whom were virally suppressed, and 308 recently (in the past 3 months) using PrEP; PrEP use was determined by using prescription records. Of 2010 tests, there were 155 positive test results, for a positivity of 7.7% (95% CI 6.6%, 9.0%) ( Among patients at a large urban FQHC, we found no significant association between HIV status and SARS-CoV-2 positive PCR results, in the first five months of the pandemic. We did find that recent PrEP users did have a high positivity to non-users, though we were not able to adjust for confounding; another study found a similar result, that warrants further investigation 8 . Similar to other research, we found increased odds of positive results among Latinx, Asian, and Black patients and lower odds among older patients. In line with our results regarding HIV status, a recent review of the literature, while limited, also suggests that comorbidities and social determinants of health play a large role in COVID-19 acquisition and severity than HIV status in the U.S. and Europe, while contradictory results have been found in South Africa. 6, 9 One possible explanation regarding PrEP is that PrEP users are engaging in more social interactions and therefore are have more exposures larger sample sizes are needed to address questions regarding viral suppression and PrEP use with COVID-19 acquisition, while sufficiently addressing confounding. Our results regarding racial and ethnic minorities are consistent with the hypothesis that minority patients are often in economic situations, such as essential work with minimal PPE or reduced financial ability to isolate or work from home that put them at increased risk for COVID-19 [10] [11] [12] [13] . This also suggests interventions, including education, testing, vaccination, and financial 6 resources for quarantine and/or isolation, should consider how to best reach these groups. Additional data are needed to understand the relationships between orientation and gender identity and COVID-19 risks, including structural and economic drivers that may expose individuals to higher risk. While we were unable to model interactions with our current sample, the higher rates among Black transwomen suggest individuals with intersecting risks may be even more likely to acquire COVID-19 Strengths of this study include the widespread community testing and access to prior patient history. Limitations include the observational nature of the study and the temporal changes in testing protocols and in COVID-19 risks; for instance, testing criteria were stricter during March and April. In addition, we did not have access to data regarding patient comorbidities (including BMI), symptoms, and disease severity, which are important areas of future research. In conclusion, we found no evidence that COVID-19 infection was associated with HIV status. Our work supports the importance of structural and systemic inequalities as drivers putting Black and Latinx patients at higher risk 10 . More work is needed to understand the intersecting risks among sexual and gender minorities. Clinical features and outcomes of HIV patients with coronavirus disease 2019 Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. The Lancet HIV Coinfection With HIV and SARS-CoV-2 in A 12-Person Case Series Outcomes Among HIV-Positive Patients Hospitalized With COVID-19 Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV Preventive efficacy of tenofovir/emtricitabine against SARS-CoV-2 among PREP users. Open Forum Infect Dis The interplay between HIV and COVID-19: summary of the data and responses to date People Living with HIV: A Syndemic Perspective Racial, Ethnic, and Geographic Disparities in Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Test Positivity in North Carolina Clinical Characteristics and Outcomes Based on Race of Hospitalized Patients With COVID-19 in a New Orleans Cohort. Open Forum Infectious Diseases Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During *Separate model for each variable, adjusted only for week of testing; Viral suppression and PrEP use were not adjusted for week, due to smaller sample size Model includes all variables (age, race, gender, orientation, insurance, and HIV status), as well as week of testing Line graphs show positivity rates at both Howard Brown Health and the entire city of Chicago 14 . Weeks marked with an asterisk had low positivity at Howard Brown Health due to clinic closures during civic unrest in the city We thank the staff at Howard Brown Health, Project VIDA and TaskForce for their COVID testing efforts and the Howard Brown patients who participated in this research. Patient Consent Statement: This study was deemed exempt by the University of Chicago and Howard Brown Health IRBs. This study did not require written consent from participants.